{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

CryptoNewsBreaks – Forward Industries, Inc. (NASDAQ: FWDI) Invests In OnRe And Plans $25M Deployment Into Tokenized Reinsurance Platform

May 5, 2026Forward Industries (NASDAQ: FWDI) announced a strategic investment in onchain reinsurance company OnRe as part of its $5 million Series A round, alongside plans to deploy up to $25 million into OnRe’s yield-bearing token ONyc on Solana, expanding its treasury strategy into tokenized real-world assets and diversified income streams. To view the full press release, visit https://ccw.


InvestorNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Appoints VP Exploration And VP Mining Operations

May 5, 2026This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced the appointments of Marc Ducharme as Vice President of Exploration and Mike Petrina as Vice President Mining Operations, strengthening its technical and operational leadership as it advances the Swanson Gold Project and prepares for a near-term restart at its Beacon Gold Mill in Québec’s Abitibi Gold Belt.


NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Initiates First Commercial Manufacturing Order For Preservative-Free Ketamine

May 5, 2026NRx Pharmaceuticals (NASDAQ: NRXP) announced it has initiated its first commercial manufacturing order of preservative-free ketamine in anticipation of potential approval under the Generic Drug User Fee Act in summer 2026, supported by stability data from multiple registration batches and a successful third-party manufacturing audit. To view the full press release, visit https://nnw.


BioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Advances Phase IIa Trial Enrollment For Concussion Treatment Candidate

May 5, 2026Oragenics (NYSE American: OGEN) announced active enrollment at a second site in its Phase IIa clinical trial evaluating ONP-002 for concussion and mild traumatic brain injury, with four patients already dosed at its initial Australian site, as the company progresses toward a planned data readout by year-end 2026. To view the full press release, visit https://ibn.


InvestorNewsBreaks – AI Maverick Intel Inc. (OTC: AIMV) Provides Update On HEAL Access Commercial Progress Ahead Of Proposed Acquisition

May 5, 2026AI Maverick Intel (OTC: AIMV) provided an update on HEAL Access Canada Inc. in connection with its previously announced LOI to acquire the company, noting more than 10 live implementations, 13 signed enterprise agreements, and a platform supporting approximately 79 clinicians and over 118,000 patients across multiple healthcare segments in North America and Europe.


AINewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Featured In AINewsWire Editorial On Service Robotics Growth

May 5, 2026Nightfood Holdings (OTCQB: NGTF) announced its inclusion in an AINewsWire editorial highlighting accelerating global demand for service robotics, with the company positioning itself for growth through scalable infrastructure, real-world deployment and strategic partnerships within the expanding AI-driven robotics market. To view the full press release, visit https://ibn.